PHASE I/II STUDY OF DDFPe AS A RADIOSENSITIZER IN GLIOBLASTOMA

被引：0
|
作者：
Unger, Evan [1 ]
Mason, Ralph [2 ,3 ]
Zhou, Heling [3 ]
Sellenger, Michael [4 ]
Ruben, Jeremy [5 ]
Lickliter, Jason [6 ]
Longacre, Olivia [7 ]
机构：
[1] Univ Arizona, Tucson, AZ USA
[2] UT Southwestern, Dept Radiol, Dallas, TX USA
[3] UT Southwestern, Dallas, TX USA
[4] Alfred Hosp, Melbourne, Vic, Australia
[5] Alfred RANZCR Training Network, William Buckland Radiotherapy Ctr, Melbourne, Vic, Australia
[6] Monash Univ, Melbourne, Vic, Australia
[7] NuvOx Pharma, Tucson, AZ USA
来源：
NEURO-ONCOLOGY | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RTHP-27
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [1] A PHASE IB/II CLINICAL TRIAL OF DODECAFLUOROPENTANE EMULSION (DDFPE) AS A RADIOSENSITIZER IN GLIOBLASTOMA
    Lickliter, Jason
    Ruben, Jeremy
    Jennens, Ross
    Kichenadasse, Ganessan
    Gzell, Cecelia
    Mason, Ralph
    Carmody, Raymond
    Becker, Jennifer
    Stea, Baldassarre
    Zhou, Heling
    Sellenger, Michael
    Longacre, Olivia
    Graham, Kaitlin
    Unger, Evan
    NEURO-ONCOLOGY, 2019, 21 : 16 - 16
  • [2] PHASE I/II CLINICAL TRIAL USING TRANS SODIUM CROCETINATE AS A RADIOSENSITIZER FOR GLIOBLASTOMA
    Gainer, John
    Sheehan, Jason
    Larner, James
    Jones, David
    NEURO-ONCOLOGY, 2014, 16
  • [3] Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
    Metro, Giulio
    Fabi, Alessandra
    Mirri, Maria A.
    Vidiri, Antonello
    Pace, Andrea
    Carosi, Mariantonia
    Russillo, Michelangelo
    Maschio, Marta
    Giannarelli, Diana
    Pellegrini, Domenica
    Pompili, Alfredo
    Cognetti, Francesco
    Carapella, Carmine M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (02) : 391 - 397
  • [4] Gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): Preliminary results of a phase II study
    Fabi, Alessandra
    Mirri, Alessandra
    Pace, Andrea
    Felici, Alessandra
    Vidiri, Antonello
    Metro, Giulio
    Cognetti, Francesco
    Occhipinti, Emanuele
    Arcangeli, Giorgio
    Carapella, Carmine
    NEURO-ONCOLOGY, 2007, 9 (04) : 530 - 530
  • [5] Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
    Giulio Metro
    Alessandra Fabi
    Maria A. Mirri
    Antonello Vidiri
    Andrea Pace
    Mariantonia Carosi
    Michelangelo Russillo
    Marta Maschio
    Diana Giannarelli
    Domenica Pellegrini
    Alfredo Pompili
    Francesco Cognetti
    Carmine M. Carapella
    Cancer Chemotherapy and Pharmacology, 2010, 65 : 391 - 397
  • [6] Prolonged gemcitabine infusion as radiosensitizer for newly diagnosed glioblastoma multiforme (GBM): A phase I study.
    Carapella, C. M.
    Mirri, A. M.
    Felici, A.
    Vidiri, A.
    Pace, A.
    Carosi, M. A.
    Occhipinti, E. M.
    Arcangeli, G.
    Cognetti, F.
    Fabi, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 78S - 78S
  • [7] INTRAGO - Intraoperative Radiotherapy for Glioblastoma - a phase I/II study
    Giordano, F. A.
    Brehmer, S.
    Schneider, F.
    Clausen, S.
    Welzel, G.
    Seitz-Rosenhagen, M.
    Schmiedek, P.
    Abo-Madyan, Y.
    Wenz, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 25 - 25
  • [8] A phase I study of Topotecan, as a radiosensitizer, for thoracic malignancies
    Forouzannia, A
    Schiller, J
    Berlin, J
    Hutson, P
    Boothman, D
    Storer, B
    Wilding, G
    Mehta, M
    LUNG CANCER, 2004, 44 (01) : 111 - 119
  • [9] A Phase 0 Study Assessing the Intracranial Activity of a Metabolic Radiosensitizer in Patients with Glioblastoma
    Elaimy, A. L.
    Al-Holou, W.
    Scott, A.
    Marini, B. L.
    Pai, A.
    Wen, B.
    Wang, L.
    Sun, D.
    Heth, J. A.
    Umemura, Y.
    Wahl, D. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E102 - E102
  • [10] PHASE II STUDY OF FIXED-DOSE RATE (FDR) GEMCITABINE AS A RADIOSENSITIZER FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Fabi, A.
    Mirri, A. M.
    Metro, G.
    Felici, A.
    Vidiri, A.
    Pace, A.
    Carosi, M. A.
    Cognetti, F.
    Occhipinti, E. M.
    Carapella, C. M.
    NEURO-ONCOLOGY, 2008, 10 (06) : 1123 - 1123
12345